Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

VLTO

Veralto Corp

Feb 10 • 04:00PM ET

92.81

+0.12 0.13 %

Industrials • Pollution & Treatment Controls • USA • NYSE

Peers: DHR MTD TMO A LDOS IQV BRKR WAT TECH

| Held by: VTI VOO VO IVV SPY VTV VOT RDVY RSP FTCS

Index	S&P 500	P/E	24.74	EPS (ttm)	3.75	Insider Own	0.28%	Shs Outstand	248.30M	Perf Week	-4.76%
Market Cap	23.04B	Forward P/E	20.33	EPS next Y	4.56	Insider Trans	-1.65%	Shs Float	247.61M	Perf Month	-9.66%
Enterprise Value	23.69B	PEG	2.41	EPS next Q	1.00	Inst Own	95.03%	Short Float	1.80%	Perf Quarter	-5.88%
Income	940.00M	P/S	4.19	EPS this Y	7.52%	Inst Trans	-0.38%	Short Ratio	2.44	Perf Half Y	-13.38%
Sales	5.50B	P/B	8.09	EPS next Y	8.85%	ROA	13.33%	Short Interest	4.45M	Perf YTD	-6.99%
Book/sh	11.47	P/C	11.35	EPS next 5Y	8.42%	ROE	36.55%	52W High	110.11 -15.71%	Perf Year	-6.99%
Cash/sh	8.18	P/FCF	22.73	EPS past 3/5Y	3.07% 5.03%	ROIC	18.51%	52W Low	83.86 10.67%	Perf 3Y	-
Dividend Est.	0.42 (0.46%)	EV/EBITDA	17.48	Sales past 3/5Y	4.16% 4.82%	Gross Margin	60.51%	Volatility	4.30% 2.46%	Perf 5Y	-
Dividend TTM	0.46 (0.50%)	EV/Sales	4.30	EPS Y/Y TTM	12.39%	Oper. Margin	23.21%	ATR (14)	2.52	Perf 10Y	-
Dividend Ex-Date	Dec 31, 2025	Quick Ratio	1.52	Sales Y/Y TTM	5.97%	Profit Margin	17.08%	RSI (14)	34.99	Recom	2.09
Dividend Gr. 3/5Y	- -	Current Ratio	1.67	EPS Q/Q	11.37%	SMA20	-5.86%	Beta	1.14	Target Price	111.44
Payout	12.23%	Debt/Eq	0.86	Sales Q/Q	3.79%	SMA50	-7.06%	Rel Volume	1.63	Prev Close	92.69
Employees	17000	LT Debt/Eq	0.64	Earnings	Feb 03 AMC	SMA200	-8.76%	Avg Volume	1.82M	Price	92.81
IPO	Sep 27, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.29% -0.69%	Trades		Volume	2,969,421	Change	0.13%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-25	Downgrade	Jefferies	Buy → Hold	$105
Sep-19-25	Initiated	Barclays	Overweight	$120
Aug-26-25	Initiated	Raymond James	Mkt Perform
May-06-25	Initiated	Northcoast	Buy	$110
Dec-12-24	Initiated	Jefferies	Buy	$125
Aug-13-24	Initiated	UBS	Neutral	$118
Jun-17-24	Initiated	TD Cowen	Hold	$95
Mar-22-24	Initiated	Goldman	Buy	$104
Mar-12-24	Initiated	Exane BNP Paribas	Outperform	$103
Feb-27-24	Initiated	BMO Capital Markets	Outperform	$97
Jan-10-24	Initiated	Deutsche Bank	Hold	$79
Jan-09-24	Initiated	Argus	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-30-23	Initiated	Stifel	Buy	$82
Nov-03-23	Initiated	RBC Capital Mkts	Sector Perform	$78
Oct-16-23	Upgrade	Vertical Research	Hold → Buy	$82
Oct-06-23	Initiated	Citigroup	Neutral	$87
Oct-03-23	Initiated	Melius	Overweight	$108
Sep-29-23	Initiated	Robert W. Baird	Neutral	$82

Show Previous Ratings

Today 12:32AM	5 Insightful Analyst Questions From Veralto's Q4 Earnings Call (StockStory)
Feb-09-26 12:06PM	UBS Lowers Veralto (VLTO) PT to $102 with Neutral Rating (Insider Monkey)
Feb-07-26 03:06AM	Veralto Q4 Earnings Call Highlights (MarketBeat)
Feb-06-26 01:49PM	Veralto's Earnings Impress, But Guidance Tempers Sentiment (Zacks)
08:01AM	Veralto price target lowered to $102 from $111 at RBC Capital (TipRanks)
04:02PM	Loading…
Feb-04-26 04:02PM	Veralto Corp (VLTO) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ... (GuruFocus.com) -6.20%
02:51PM	Analyst Report: Veralto Corporation (Morningstar Research)
01:40PM	VLTO Q4 Deep Dive: Macro Uncertainty and Integration Costs Shape 2026 Outlook (StockStory)
Feb-03-26 05:45PM	Veralto (VLTO) Q4 Earnings Surpass Estimates (Zacks)
05:22PM	Veralto (NYSE:VLTO) Misses Q4 CY2025 Sales Expectations (StockStory)
04:58PM	Veralto: Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	Veralto Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
Feb-01-26 10:09PM	Earnings To Watch: Veralto (VLTO) Reports Q4 Results Tomorrow (StockStory)
Jan-29-26 11:43AM	Veralto Gears Up to Report Q4 Earnings: What's in the Offing? (Zacks)
Jan-28-26 01:22PM	Analyst Report: Danaher Corporation (Morningstar Research)
10:04AM	Loading…
Jan-19-26 10:04AM	Reasons Why Investors Can Consider Buying Veralto Stock Now (Zacks)
Jan-15-26 11:26AM	Reasons Why You Should Retain WM Stock in Your Portfolio (Zacks)
Jan-14-26 08:30AM	Veralto Schedules Fourth Quarter 2025 Earnings Call (PR Newswire)
Jan-13-26 04:32PM	Analyst Report: Danaher Corporation (Morningstar Research)
Jan-12-26 04:56AM	Here's What to Expect From Veraltos Next Earnings Report (Barchart)
Jan-07-26 12:38PM	Here's Why You Should Retain FactSet Stock in Your Portfolio Now (Zacks)
Dec-30-25 09:13AM	Reasons Why Investors Can Consider Buying ADP Stock Now (Zacks)
Dec-29-25 12:55PM	Here's Why You Should Retain IQV Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:40AM	Here's Why You Should Retain WCN Stock in Your Portfolio Now (Zacks)
Dec-24-25 09:40AM	Is OppFi (OPFI) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Dec-16-25 08:00AM	Veralto Announces Increase in Quarterly Dividend (PR Newswire)
Dec-14-25 11:33PM	3 Mid-Cap Stocks We Find Risky (StockStory)
Dec-12-25 11:27AM	Reasons Why Investors Can Consider Buying Veralto Stock Now (Zacks)
Dec-10-25 02:13PM	Jefferies upgrades Pentair, John Bean and Middleby among multi industrials (Investing.com)
11:25AM	Is Veralto Corporation Stock Underperforming the S&P 500? (Barchart)
09:40AM	Loading…
09:40AM	Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls (The Fly)
09:09AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More (24/7 Wall St.)
Dec-09-25 11:05PM	2 Reasons VLTO is Risky and 1 Stock to Buy Instead (StockStory)
Dec-04-25 07:12AM	Here's Why You Should Retain Equifax Stock in Your Portfolio Now (Zacks)
Nov-28-25 12:16PM	Here's Why Investors Should Retain TransUnion Stock for Now (Zacks)
Nov-27-25 11:30AM	Why Is Veralto (VLTO) Up 1.8% Since Last Earnings Report? (Zacks)
Nov-25-25 07:00AM	Veralto Announces Agreement to Acquire In-Situ and Establishes $750 Million Share Repurchase Program (PR Newswire) +5.93%
Nov-24-25 12:00PM	Veralto (VLTO) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-23-25 10:35PM	Q3 Rundown: Veralto (NYSE:VLTO) Vs Other Environmental and Facilities Services Stocks (StockStory)
Nov-18-25 08:20AM	Is Wall Street Bullish or Bearish on Veralto Stock? (Barchart)
Nov-11-25 08:18AM	Buy 5 Business Services Sector Stocks to Boost Your Portfolio Stability (Zacks)
Nov-04-25 12:36AM	5 Insightful Analyst Questions From Veralto's Q3 Earnings Call (StockStory)
Nov-03-25 08:15AM	Veralto Appoints Kim Chainey as Chief Legal Officer (PR Newswire)
Oct-30-25 11:40AM	Analyst Report: Veralto Corporation (Morningstar Research)
Oct-29-25 02:30PM	VLTO Q3 Deep Dive: Tariff Mitigation, Data Center Growth, and Margin Trends (StockStory)
12:27PM	Analyst Report: Veralto Corporation (Morningstar Research)
11:45AM	Veralto Q3 Earnings & Revenues Beat Estimates, Increase Y/Y (Zacks)
Oct-28-25 05:50PM	Veralto (NYSE:VLTO) Reports Q3 In Line With Expectations (StockStory)
05:40PM	Veralto (VLTO) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:37PM	Veralto: Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Veralto Reports Third Quarter 2025 Results (PR Newswire)
Oct-27-25 03:43PM	Veralto Gears Up to Report Q3 Earnings: Here's What You Should Know (Zacks)
Oct-26-25 11:14PM	Veralto (VLTO) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-21-25 02:12PM	Analyst Report: Danaher Corporation (Morningstar Research)
Oct-17-25 12:22PM	3 Industrials Stocks That Concern Us (StockStory)
Oct-16-25 10:06AM	Select Water Solutions, Inc. (WTTR) Surges 14.0%: Is This an Indication of Further Gains? (Zacks)
Oct-10-25 04:55PM	Water Is a Tricky Investment. Here Are Wall Street's Favorite Stocks. (Barrons.com)
Oct-09-25 06:51PM	Analyst Report: Veralto Corporation (Morningstar Research)
Oct-08-25 08:00AM	Veralto Schedules Third Quarter 2025 Earnings Call (PR Newswire)
Oct-03-25 08:09AM	Earnings Preview: What to Expect From Veralto's Report (Barchart)
Oct-01-25 09:30AM	VLTO Water Grows on Strong Industrial, Municipal Tailwinds (Zacks)
Sep-22-25 09:41AM	Cintas Set to Report Q1 Earnings: Here's What to Expect (Zacks)
Sep-18-25 08:00AM	Veralto Announces Quarterly Dividend (PR Newswire)
Sep-17-25 08:41AM	How Is Veralto's Stock Performance Compared to Other Environmental Services Stocks? (Barchart)
Sep-11-25 11:35PM	Environmental and Facilities Services Stocks Q2 Results: Benchmarking Veralto (NYSE:VLTO) (StockStory)
Aug-28-25 12:01AM	Veralto (VLTO): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-27-25 11:30AM	Veralto (VLTO) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-22-25 03:48AM	Are Wall Street Analysts Bullish on Veralto Stock? (Barchart)
Aug-21-25 12:00PM	All You Need to Know About Veralto (VLTO) Rating Upgrade to Buy (Zacks)
Aug-20-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Aug-15-25 11:27AM	Veralto Benefits From TraceGains Buyout Amid High Competition (Zacks)
Aug-12-25 11:32PM	VLTO Q2 Deep Dive: Secular Demand and Strategic Investments Drive Steady Growth (StockStory)
11:31PM	5 Insightful Analyst Questions From Veralto's Q2 Earnings Call (StockStory)
Aug-06-25 08:22AM	Built for AI, Designed for Uptime \| ChemTreat Launches CTSolutions® D2C for Direct-to-Chip Data Center Cooling (PR Newswire)
Aug-04-25 09:50AM	Veralto (VLTO) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:00AM	AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer (Business Wire)
Jul-29-25 02:09PM	Analyst Report: Veralto Corporation (Morningstar Research)
10:07AM	Veralto Q2 Earnings & Revenues Beat Estimates, Increase Y/Y (Zacks)
Jul-28-25 08:00PM	Here's What Key Metrics Tell Us About Veralto (VLTO) Q2 Earnings (Zacks)
06:01PM	Veralto (NYSE:VLTO) Surprises With Q2 Sales (StockStory)
05:40PM	Veralto (VLTO) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:35PM	Veralto: Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	Veralto Reports Second Quarter 2025 Results (PR Newswire)
11:11AM	Veralto Commits 20M to Emerald's Global Water Fund II as Cornerstone Investor (Insider Monkey)
Jul-26-25 11:03PM	Earnings To Watch: Veralto (VLTO) Reports Q2 Results Tomorrow (StockStory)
Jul-25-25 12:32AM	1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down (StockStory)
Jul-23-25 11:06AM	Veralto Gears Up to Report Q2 Earnings: Here's What You Should Know (Zacks)
06:20AM	Should You Invest in the First Trust Water ETF (FIW)? (Zacks)
Jul-22-25 10:28AM	Analyst Report: Danaher Corporation (Morningstar Research)
10:00AM	Republic Services (RSG) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:30AM	Veralto Commits 20M to Emerald's New Fund to Accelerate Water Innovation Solutions (PR Newswire)
06:02AM	Danaher Announces Transition Plan for Chief Financial Officer (PR Newswire)
Jul-21-25 10:00AM	Veralto (VLTO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:19AM	Rollins Gears Up to Report Q2 Earnings: Here's What You Should Know (Zacks)
Jul-18-25 09:36AM	Omnicom Group Stock Barely Moves Since Q2 Earnings Beat (Zacks)
Jul-17-25 10:55AM	Equifax Gears Up to Report Q2 Earnings: What's in the Offing? (Zacks)
Jul-16-25 09:46AM	Interpublic Group to Report Q2 Earnings: What's in the Offing? (Zacks)
09:42AM	IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-10-25 09:22AM	Omnicom Gears Up to Report Q2 Earnings: What's in the Cards? (Zacks)
08:00AM	Veralto Schedules Second Quarter 2025 Earnings Call (PR Newswire)

Veralto Corp. engages in the provision of environmental and applied solutions. Its segments include Water Quality and Product Quality & Innovation. The Water Quality segment provides comprehensive portfolios of water analytics and differentiated water treatment solutions that enable the reliable delivery of safe drinking water by public and private utilities. The Product Quality & Innovation segment provides a broad set of solutions for brand owners and consumer packaged goods companies that enable speed to market as well as traceability and quality control of their products. The company was founded on October 26, 2022 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bystrom Mattias	SVP, PQI	Dec 01 '25	Sale	101.73	1,000	101,730	31,430	Dec 02 05:45 PM
Bystrom Mattias	Officer	Dec 01 '25	Proposed Sale	101.73	1,000	101,735		Dec 01 02:39 PM
Beneteau Lesley	SVP, CHRO	Nov 14 '25	Option Exercise	23.64	1,622	38,344	15,000	Nov 17 06:02 PM
Honeycutt Jennifer	President and CEO	Aug 29 '25	Option Exercise	28.76	10,646	306,179	116,865	Sep 02 05:45 PM
Honeycutt Jennifer	President and CEO	Aug 29 '25	Sale	106.26	10,646	1,131,244	106,219	Sep 02 05:45 PM
Honeycutt Jennifer	Officer	Aug 29 '25	Proposed Sale	106.26	10,646	1,131,244		Aug 29 10:45 AM
Trivedi Surekha	SVP, Strategy & Sustainability	Jun 02 '25	Sale	100.55	848	85,266	8,433	Jun 04 05:22 PM
Trivedi Surekha	Officer	Jun 02 '25	Proposed Sale	100.55	848	85,266		Jun 02 10:04 AM
Beneteau Lesley	SVP, CHRO	May 15 '25	Option Exercise	22.32	712	15,892	14,029	May 16 05:22 PM
Beneteau Lesley	SVP, CHRO	May 15 '25	Sale	100.84	458	46,185	13,571	May 16 05:22 PM
Beneteau Lesley	Officer	May 15 '25	Proposed Sale	100.84	458	46,185		May 15 04:23 PM
Bystrom Mattias	SVP, PQI	May 12 '25	Sale	99.96	2,500	249,906	32,430	May 14 05:31 PM
Bystrom Mattias	Officer	May 12 '25	Proposed Sale	99.96	2,500	249,907		May 12 06:18 PM
Aquino Melissa	SVP, Water Quality	May 01 '25	Option Exercise	83.23	26,587	2,212,836	38,744	May 05 05:26 PM
Aquino Melissa	SVP, Water Quality	May 01 '25	Sale	93.67	31,689	2,968,245	17,434	May 05 05:26 PM
Trivedi Surekha	SVP, Strategy & Sustainability	May 01 '25	Sale	96.54	590	56,959	9,421	May 05 05:24 PM
Skeete Bernard M	Chief Accounting Officer	May 01 '25	Sale	94.40	450	42,480	4,087	May 05 05:23 PM
Honeycutt Jennifer	President and CEO	Apr 30 '25	Sale	95.00	10,418	989,710	106,219	May 01 05:21 PM
Aquino Melissa	Officer	May 01 '25	Proposed Sale	93.67	31,689	2,968,265		May 01 01:24 PM
Trivedi Surekha	Officer	May 01 '25	Proposed Sale	96.54	590	56,959		May 01 10:16 AM
Honeycutt Jennifer	Officer	Apr 30 '25	Proposed Sale	95.00	10,418	989,710		Apr 30 02:45 PM
Trivedi Surekha	SVP, Strategy & Sustainability	Apr 01 '25	Sale	97.05	590	57,260	10,011	Apr 02 05:23 PM
Trivedi Surekha	Officer	Apr 01 '25	Proposed Sale	97.05	590	57,260		Apr 01 10:46 AM
Honeycutt Jennifer	President and CEO	Mar 24 '25	Sale	98.56	10,414	1,026,404	116,637	Mar 25 05:20 PM
Honeycutt Jennifer	Officer	Mar 24 '25	Proposed Sale	98.56	10,414	1,026,404		Mar 24 10:30 AM
Trivedi Surekha	SVP, Strategy & Sustainability	Feb 25 '25	Sale	100.35	590	59,206	8,470	Feb 26 05:10 PM
Honeycutt Jennifer	President and CEO	Feb 25 '25	Sale	100.35	10,414	1,045,045	104,496	Feb 26 05:06 PM
Trivedi Surekha	Officer	Feb 25 '25	Proposed Sale	100.35	590	59,206		Feb 25 02:22 PM
Honeycutt Jennifer	Officer	Feb 25 '25	Proposed Sale	100.35	10,414	1,045,045		Feb 25 10:22 AM
Aquino Melissa	SVP, Water Quality	Feb 11 '25	Sale	99.60	463	46,115	20,761	Feb 13 05:03 PM
Aquino Melissa	Officer	Feb 11 '25	Proposed Sale	99.60	463	46,115		Feb 11 09:47 AM

Open in Screener

DHR

Danaher Corp

Feb 10 • 04:00PM ET

219.75

+3.09 1.43 %

Healthcare • Diagnostics & Research • USA • NYSE

Peers: GE HON MMM ROK KEYS ABT TMO MTD BSX

| Held by: VTI VOO IVV SPY VTV XLV VIG VHT JEPI MOAT

Index	S&P 500	P/E	43.54	EPS (ttm)	5.05	Insider Own	8.81%	Shs Outstand	706.90M	Perf Week	1.45%
Market Cap	155.22B	Forward P/E	24.11	EPS next Y	9.11	Insider Trans	-1.76%	Shs Float	644.13M	Perf Month	-7.81%
Enterprise Value	169.03B	PEG	2.78	EPS next Q	1.94	Inst Own	82.63%	Short Float	1.11%	Perf Quarter	4.67%
Income	3.61B	P/S	6.32	EPS this Y	7.87%	Inst Trans	-0.02%	Short Ratio	1.93	Perf Half Y	10.01%
Sales	24.57B	P/B	2.96	EPS next Y	8.31%	ROA	4.47%	Short Interest	7.14M	Perf YTD	-4.01%
Book/sh	74.32	P/C	33.63	EPS next 5Y	8.66%	ROE	7.05%	52W High	242.80 -9.49%	Perf Year	7.99%
Cash/sh	6.53	P/FCF	29.59	EPS past 3/5Y	-19.38% 0.67%	ROIC	5.09%	52W Low	171.00 28.51%	Perf 3Y	-4.22%
Dividend Est.	1.32 (0.60%)	EV/EBITDA	21.99	Sales past 3/5Y	-2.67% 1.97%	Gross Margin	68.77%	Volatility	2.24% 2.70%	Perf 5Y	4.39%
Dividend TTM	1.28 (0.58%)	EV/Sales	6.88	EPS Y/Y TTM	-4.81%	Oper. Margin	21.32%	ATR (14)	5.64	Perf 10Y	283.87%
Dividend Ex-Date	Dec 26, 2025	Quick Ratio	1.51	Sales Y/Y TTM	2.90%	Profit Margin	14.71%	RSI (14)	42.00	Recom	1.39
Dividend Gr. 3/5Y	8.58% 12.20%	Current Ratio	1.87	EPS Q/Q	12.65%	SMA20	-3.72%	Beta	0.93	Target Price	264.18
Payout	25.35%	Debt/Eq	0.35	Sales Q/Q	4.59%	SMA50	-4.01%	Rel Volume	1.19	Prev Close	216.66
Employees	63000	LT Debt/Eq	0.35	Earnings	Jan 28 BMO	SMA200	5.12%	Avg Volume	3.69M	Price	219.75
IPO	Dec 10, 1969	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.11% 0.40%	Trades		Volume	4,405,749	Change	1.43%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Goldman	Buy	$265
Dec-02-25	Initiated	Morgan Stanley	Overweight	$270
Oct-08-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$220
Jul-11-25	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$275
Apr-10-25	Upgrade	Barclays	Equal Weight → Overweight	$205
Mar-21-25	Upgrade	Goldman	Neutral → Buy	$260
Mar-14-25	Upgrade	Stifel	Hold → Buy	$260
Feb-03-25	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-23-24	Initiated	Scotiabank	Sector Perform
Dec-19-24	Initiated	Guggenheim	Buy	$275
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$290
Oct-31-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$285
Oct-01-24	Initiated	Stephens	Overweight	$315
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$280
Jun-03-24	Resumed	Jefferies	Buy	$295
Apr-17-24	Upgrade	HSBC Securities	Hold → Buy	$280
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight	$240
Dec-18-23	Initiated	HSBC Securities	Hold
Dec-13-23	Resumed	Wolfe Research	Peer Perform
Dec-07-23	Downgrade	Goldman	Buy → Neutral	$215 → $205

Show Previous Ratings

Feb-09-26 11:40AM	BLCO or DHR: Which Is the Better Value Stock Right Now? (Zacks)
Feb-05-26 03:00AM	Exclusive: Lawhive, a startup using AI to reimagine the general practice law firm, raises $60 million in new venture capital funding (Fortune)
Feb-04-26 04:00PM	Danaher Corporation (DHR): A Bull Case Theory (Insider Monkey)
12:41AM	The Top 5 Analyst Questions From Danaher's Q4 Earnings Call (StockStory)
Feb-02-26 10:28AM	Revvity Sees Steady Growth On Rising Demand From Pharma/Biotech Customers (Benzinga)
12:31AM	Loading…
Jan-29-26 12:31AM	DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets (StockStory)
Jan-28-26 04:32PM	Stocks Finish Mixed as Fed Keeps Interest Rates Steady (Barchart)
02:02PM	Danaher Corp (DHR) Q4 2025 Earnings Call Highlights: Strong Finish with Robust Free Cash Flow ... (GuruFocus.com)
01:22PM	Analyst Report: Danaher Corporation (Morningstar Research)
01:01PM	Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? (Benzinga)
11:15AM	Stocks Mixed After the Fed Pauses Rate Cuts (Barchart)
10:55AM	Danaher Q4 Earnings Beat Estimates, Life Sciences Sales Up Y/Y (Zacks)
10:09AM	Danaher Q4 Earnings Call Highlights (MarketBeat)
09:46AM	Danaher Expects Gradual Improvement In End-Market Conditions (Benzinga)
09:30AM	Compared to Estimates, Danaher (DHR) Q4 Earnings: A Look at Key Metrics (Zacks)
07:10AM	Loading…
07:10AM	Danaher (DHR) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:42AM	Danaher beats Q4 expectations as bioprocessing business shows strength (Investing.com)
06:19AM	Danaher (NYSE:DHR) Posts Q4 CY2025 Sales In Line With Estimates (StockStory)
06:17AM	Danaher: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
Jan-26-26 10:07PM	What To Expect From Danaher's (DHR) Q4 Earnings (StockStory)
09:33PM	Jim Cramer on Danaher: "This Could Be the First Truly Strong Quarter in Years" (Insider Monkey)
10:00AM	Revvity (RVTY) Earnings Expected to Grow: Should You Buy? (Zacks)
08:20AM	Tesla, Microsoft, Meta, SanDisk And More: Stocks With Earnings This Week (Benzinga)
Jan-25-26 07:52AM	Big Tech earnings, Fed meeting feature as markets end January with busiest week of Q1: What to watch (Yahoo Finance)
Jan-23-26 04:20PM	Analysts consider potential Qiagen deal amid reported strategic review (Investing.com)
09:15AM	Insights Into Danaher (DHR) Q4: Wall Street Projections for Key Metrics (Zacks)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
07:17AM	Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings? (Zacks)
Jan-21-26 10:00AM	Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
11:06PM	Loading…
Jan-20-26 11:06PM	3 Reasons to Avoid DHR and 1 Stock to Buy Instead (StockStory)
Jan-19-26 11:02PM	3 Reasons DHR is Risky and 1 Stock to Buy Instead (StockStory)
07:37AM	Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings? (Zacks)
Jan-18-26 10:35PM	Q3 Rundown: Danaher (NYSE:DHR) Vs Other Research Tools & Consumables Stocks (StockStory)
12:54AM	Danaher Corporation (DHR) Maintains Buy Rating as Analysts See Upside in 2026 (Insider Monkey)
Jan-15-26 05:51AM	Health Care Roundup: Market Talk (The Wall Street Journal)
Jan-14-26 01:44PM	JPM26: Danaher positioned to improve patient diagnostics (Medical Device Network)
07:57AM	Danaher (DHR) Rebounded on Accelerated Demand (Insider Monkey)
Jan-13-26 04:32PM	Analyst Report: Danaher Corporation (Morningstar Research)
Jan-12-26 03:58PM	CIO sees healthcare as a great potential investment in 2026 (Reuters Videos)
09:00AM	Danaher CEO to Comment on Financial Performance (PR Newswire)
Jan-08-26 08:00AM	This Stock Is Ready to Put Its Post-Covid Malaise Behind It (Barrons.com)
Jan-07-26 06:21AM	Here's What to Expect From Danaher's Next Earnings Report (Barchart)
Jan-05-26 04:15PM	Danaher to Present at J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-25 10:08AM	Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain? (Zacks)
Dec-24-25 11:48AM	HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Dec-23-25 11:40AM	The Bill Gates Portfolio: 3 Of His Ancor Holdings Every Investor Should Consider (24/7 Wall St.)
Dec-21-25 09:44AM	Goldman Sachs and KeyBanc are Bullish on Danaher (DHR) (Insider Monkey)
Dec-18-25 09:55AM	Will Strength in Biotechnology Unit Continue to Drive Danaher's Growth? (Zacks)
Dec-17-25 07:30AM	Danaher Schedules Fourth Quarter 2025 Earnings Conference Call (PR Newswire)
Dec-16-25 07:36AM	InnovAge (INNV) Moves 7.8% Higher: Will This Strength Last? (Zacks)
Dec-15-25 06:30AM	How Is Revvity's Stock Performance Compared to Other Health Care Stocks? (Barchart)
Dec-09-25 04:15PM	Danaher Announces Quarterly Dividend (PR Newswire)
08:16AM	Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy (Investing.com)
Dec-05-25 06:09AM	Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks (TipRanks)
Dec-04-25 01:59PM	Danaher Corporation (DHR): A Bull Case Theory (Insider Monkey)
01:53PM	Danaher Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
12:05AM	Jim Cramer Says "Danaher's Been Acting Much Better" (Insider Monkey)
Nov-28-25 06:34PM	HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-26-25 04:58PM	DuPont Can Become a Compounder. Why the Stock Could Gain 20%. (Barrons.com)
11:30AM	Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue? (Zacks)
07:48AM	Danaher Stock: Is DHR Underperforming the Healthcare Sector? (Barchart)
Nov-25-25 01:03PM	DuPont Can Become a 'Compounder.' Why the Stock Could Gain 20%. (Barrons.com)
Nov-20-25 11:30AM	Danaher (DHR) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-12-25 09:45PM	Danaher Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
11:40AM	SOLV vs. DHR: Which Stock Is the Better Value Option? (Zacks)
10:00AM	2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon (Motley Fool)
Nov-11-25 04:15PM	Danaher to Present at Jefferies Global Healthcare Conference (PR Newswire)
Nov-10-25 11:40AM	SOLV or DHR: Which Is the Better Value Stock Right Now? (Zacks)
Nov-04-25 04:26AM	Tala Health raises $100 million seed round, as Ritankar Das seeks to build a holding company for the AI era (Fortune)
Oct-30-25 11:41AM	The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now (24/7 Wall St.)
Oct-28-25 01:34AM	5 Must-Read Analyst Questions From Danaher's Q3 Earnings Call (StockStory)
Oct-27-25 09:15AM	Unlocking Danaher (DHR) International Revenues: Trends, Surprises, and Prospects (Zacks)
Oct-24-25 11:52AM	Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
09:30AM	DHR Q3 2025 Deep Dive: Bioprocessing, Diagnostics, and Productivity Initiatives Amid Policy Shifts (StockStory)
Oct-23-25 09:20AM	Jim Cramer Says "Danaher Gave Us the Quarter We've Been Looking For" (Insider Monkey)
Oct-22-25 02:48PM	Danaher (DHR) Jumps on Improved Q3 Earnings (Insider Monkey)
09:21AM	Company News for Oct 22, 2025 (Zacks)
07:29AM	Jim Cramer Calls Danaher "Once Incredibly Well-Run Company" (Insider Monkey)
Oct-21-25 05:08PM	Stocks to Watch Tuesday Recap: Warner Bros. Discovery, GM, GE Aerospace (The Wall Street Journal) +5.94%
04:05PM	Danaher Surges Into Buy Zone As One Key Division Drives Growth (Investor's Business Daily)
03:00PM	Danaher Corp (DHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Share ... (GuruFocus.com)
02:17PM	Here's Why Shares in Danaher Got Boosted Higher Today (Motley Fool)
02:12PM	Analyst Report: Danaher Corporation (Morningstar Research)
01:41PM	Why Danaher (DHR) Stock Is Trading Up Today (StockStory)
01:35PM	Danaher Third-Quarter Earnings Rise; Pharma R&D Spend Expected to Rebound (The Wall Street Journal)
12:40PM	Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y (Zacks)
11:42AM	Danaher Tops Its 5% Chase Zone As One Key Division Drives Growth (Investor's Business Daily)
09:42AM	Stocks to Watch Tuesday: Warner Bros. Discovery, GM, GE Aerospace (The Wall Street Journal)
09:30AM	Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:15AM	Danaher (DHR) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:44AM	Danaher beats Q3 forecasts, issues soft full-year profit outlook; shares slip (Investing.com)
06:23AM	Danaher Sales and Profit Rise on Bioprocessing Momentum (The Wall Street Journal)
06:17AM	Danaher's (NYSE:DHR) Q3 Sales Beat Estimates (StockStory)
06:09AM	Danaher: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports Third Quarter 2025 Results (PR Newswire)
Oct-20-25 11:40AM	LH vs. DHR: Which Stock Is the Better Value Option? (Zacks)
Oct-19-25 11:04PM	Danaher Earnings: What To Look For From DHR (StockStory)
07:33AM	Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week (Yahoo Finance)
Oct-17-25 10:18AM	Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? (Zacks)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RALES MITCHELL P	Chairman of Exec. Committee	Nov 25 '25	Sale	230.38	40,625	9,359,067	850,000	Nov 26 04:30 PM
The Mitchell P. Rales Family T	See Remarks	Nov 25 '25	Proposed Sale	226.98	40,625	9,221,063		Nov 25 05:23 PM
Glenstone Foundation	See Remarks	Nov 25 '25	Proposed Sale	226.98	146,957	33,356,300		Nov 25 05:22 PM
List Teri	Director	Nov 18 '25	Option Exercise	71.88	3,298	237,060	24,060	Nov 19 05:00 PM
List Teri	Director	Nov 18 '25	Sale	226.50	3,298	746,997	20,762	Nov 19 05:00 PM
List Teri	Director	Nov 18 '25	Proposed Sale	226.50	3,298	746,997		Nov 18 03:32 PM
McGrew Matthew	EVP & Chief Financial Officer	Nov 11 '25	Option Exercise	62.85	16,172	1,016,410	36,234	Nov 13 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Nov 11 '25	Sale	214.62	16,172	3,470,831	20,062	Nov 13 05:00 PM
Ellis Brian W	Senior Vice President - GC	Nov 12 '25	Option Exercise	58.59	21,776	1,275,856	29,220	Nov 13 05:00 PM
Ellis Brian W	Senior Vice President - GC	Nov 12 '25	Sale	219.23	21,776	4,773,863	14,553	Nov 13 05:00 PM
RALES MITCHELL P	Chairman of Exec. Committee	Nov 12 '25	Sale	218.69	437,000	95,566,167	553,228	Nov 13 04:30 PM
Couchara Georgeann	SVP, Human Resources	Nov 10 '25	Option Exercise	88.24	4,176	368,490	7,799	Nov 12 05:00 PM
Couchara Georgeann	SVP, Human Resources	Nov 10 '25	Sale	210.42	5,174	1,088,704	2,625	Nov 12 05:00 PM
Mitchell P. Rales	Dir; Chmn. of Exec. Comm.	Nov 12 '25	Proposed Sale	209.94	437,000	91,743,780		Nov 12 04:30 PM
Ellis Brian W	Officer	Nov 12 '25	Proposed Sale	219.23	21,776	4,773,864		Nov 12 02:35 PM
McGrew Matthew	Officer	Nov 11 '25	Proposed Sale	214.62	16,172	3,470,831		Nov 12 08:56 AM
Couchara Georgeann	Officer	Nov 10 '25	Proposed Sale	210.42	5,174	1,088,704		Nov 10 02:46 PM
RALES MITCHELL P	Chairman of Exec. Committee	Oct 31 '25	Sale	216.06	600,000	129,636,027	990,228	Nov 04 04:30 PM
Mitchell P. Rales	Dir; Chmn. of Exec. Comm.	Oct 31 '25	Proposed Sale	214.01	600,000	128,406,000		Oct 31 06:38 PM
List Teri	Director	Aug 22 '25	Sale	211.06	2,778	586,319	20,751	Aug 25 05:00 PM
List Teri	Director	Aug 22 '25	Proposed Sale	211.06	2,778	586,320		Aug 22 12:18 PM
LOHR WALTER G	Former Director	Jul 22 '25	Proposed Sale	188.15	2,719	511,588		Jul 22 11:49 AM
Zerhouni Elias A.	Director	Jul 15 '25	Option Exercise	59.34	3,928	233,088	42,014	Jul 16 05:01 PM
SCHWIETERS JOHN T	Director	Jul 15 '25	Option Exercise	59.34	3,928	233,088	21,024	Jul 16 05:01 PM
List Teri	Director	Jul 02 '25	Option Exercise	59.34	3,928	233,088	24,667	Jul 07 05:00 PM
RALES STEVEN M	Chairman	May 12 '25	Sale	196.74	1,250,000	245,919,391	3,105,808	May 14 05:19 PM
RALES STEVEN M	Officer	May 12 '25	Proposed Sale	194.82	1,250,000	243,525,000		May 12 09:30 PM
Raskas Daniel	Former Officer	May 02 '25	Proposed Sale	201.03	7,053	1,417,865		May 02 10:45 AM
Riley Christopher Paul	Executive Vice President	Apr 30 '25	Option Exercise	76.47	7,801	596,542	30,984	May 01 05:01 PM
Riley Christopher Paul	Executive Vice President	Apr 30 '25	Sale	198.00	15,805	3,129,424	15,179	May 01 05:01 PM
Riley Christopher Paul	Officer	Apr 30 '25	Proposed Sale	198.00	15,805	3,129,421		Apr 30 03:41 PM
Glenstone Foundation	See Remarks	Apr 24 '25	Proposed Sale	196.50	598,281	117,562,216		Apr 24 05:28 PM
King William	Former Officer	Mar 11 '25	Proposed Sale	207.14	64,697	13,401,340		Mar 11 04:03 PM
King William	Officer	Feb 21 '25	Proposed Sale	209.97	114,351	24,010,531		Feb 21 04:18 PM
Sabeti Pardis C	former Board of Directors	Feb 18 '25	Proposed Sale	204.28	4,337	885,953		Feb 18 01:04 PM

VLTO

Veralto Corp

DHR

Danaher Corp

Upgrade your FINVIZ experience